Early Phase 1 Parkinson's Disease Trial, Recruiting NCT06540989 Sponsor: Teachers College, Columbia University Condition: Parkinson's Disease
Back to Parkinsons Disease

Early Phase 1 Parkinson's Disease Trial, Recruiting

NCT06540989
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 50 and 80 years old
  • People who have been medically diagnosed with Parkinson's disease (PD)
  • People whose Parkinson's disease falls within stages I to IV on a standard scale used to measure how advanced the condition is (the Hoehn & Yahr Scale)
  • People whose Parkinson's disease medications have been at a stable, unchanged dose for a period of time
  • People who have mild to moderate difficulties with speech clarity related to Parkinson's disease (called dysarthria)
  • People who score 25 or above on a standard memory and thinking test called the MMSE, indicating no significant cognitive impairment
  • People who score 24 or below on a standard mood questionnaire called the BDI-III, indicating depression symptoms are within a certain range

Who may not be able to join:

  • People who have an atypical form of parkinsonism, or any other neurological condition, at the time of screening
  • People who have previously had a type of brain surgery for Parkinson's disease known as deep brain stimulation (DBS)
  • People who received an intensive voice or speech treatment program less than three months before joining this study
  • People who have a speech or voice condition that is not related to their Parkinson's disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Gemma Moya-Galé, Ph.D., Teachers College, Columbia University

Phone: 212-678-3323

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Teachers College, Columbia University
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
31 January 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Intelligibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov